Validation of Pediatric Patient Reported Outcomes in Chronic Diseases (PEPR) Consortium (U19)
The summary for the Validation of Pediatric Patient Reported Outcomes in Chronic Diseases (PEPR) Consortium (U19) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Validation of Pediatric Patient Reported Outcomes in Chronic Diseases (PEPR) Consortium (U19): The purpose of this FOA is to solicit applications for the Validation of Pediatric Patient Reported Outcomes in Chronic Diseases (PEPR) Consortium. The NIAMS, on behalf of the National Institutes of Health, intends to capitalize on recent advances in the science of Patient Reported Outcomes (PROs) to measure the patient experience in clinical care and research in children with a variety of chronic diseases and conditions (e.g., asthma, juvenile arthritis, cystic fibrosis, diabetes, obesity and overweight, chronic kidney disease, inflammatory bowel disease, sickle cell disease, malnutrition, developmental disabilities including attention deficit/hyperactivity disorder and autism spectrum disorder, cerebral palsy and mental illnesses) using the Patient-Reported Outcomes Measurement Information System (PROMIS) tools and approaches coupled with detailed clinical phenotyping and/or biospecimen collection in well-characterized human cohorts. The Patient Reported Outcomes Measurement Information System (PROMIS) is a system of highly reliable, precise measures of patientreported health status for physical, mental, and social wellbeing. PROMIS tools measure what patients are able to do and how they feel by asking questions. PROMIS measures can be used as primary or secondary endpoints in clinical studies of the effectiveness of treatment.
|Federal Grant Title:||Validation of Pediatric Patient Reported Outcomes in Chronic Diseases (PEPR) Consortium (U19)|
|Federal Agency Name:||National Institutes of Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||RFA-AR-15-014|
|Type of Funding:||Cooperative Agreement|
|CFDA Descriptions:||Arthritis, Musculoskeletal and Skin Diseases Research|
|Current Application Deadline:||Jun 1, 2015|
|Original Application Deadline:||Jun 1, 2015|
|Posted Date:||Mar 6, 2015|
|Creation Date:||Mar 6, 2015|
|Archive Date:||Jul 2, 2015|
|Total Program Funding:||$12,000,000|
|Maximum Federal Grant Award:||none|
|Minimum Federal Grant Award:||none|
|Expected Number of Awards:||4|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- Special district governments
Independent school districts
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Private institutions of higher education
Public and State controlled institutions of higher education
For profit organizations other than small businesses
City or township governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal governments (Federally recognized)
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Native American tribal organizations (other than Federally recognized tribal governments)
- Additional Information on Eligibility
- Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
- Link to Full Grant Announcement
- Grant Announcement Contact
- NIH OER Webmaster
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
National Institutes of Health 301-496-3405
- Similar Government Grants
- • Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (S...
- • Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed...
- • Mechanistic Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed...
- • Limited Competition: Small Grant Program for NIAMS K08 and K23 Recipients (R03)
- • Supplements to Advance Research (STAR) from Projects to Programs (Admin Supp)- Clinical Tr...
- • Collaborative Arthritis and Musculoskeletal and Skin Diseases Science Award (Camssa)
- • Niams Small Grant Program for New Investigators
- • Skin Diseases Research Core Centers
- More Grants from the National Institutes of Health
- • Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
- • A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
- • Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
- • HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
- • National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...